Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

about

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

P2860

Q59125874-0274A61E-59FA-4AE1-B7BD-06FCC9239A50

P2860

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

Item

http://www.wikidata.org/entity/Q48369805

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@en

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@nl

type

Item

label

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@en

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@nl

prefLabel

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@en

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

@nl

P1476

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro

@en

P2093

Guo-Xin Hu

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Jian-Ping Cai

http://www.w3.org/2001/XMLSchema#string

Li-Qun Zhang

http://www.w3.org/2001/XMLSchema#string

Meng-Fang Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Xia Hu

http://www.w3.org/2001/XMLSchema#string

P2860

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions

A Review of Nebivolol Pharmacology and Clinical Evidence

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.

Pharmacogenetics: from bench to byte--an update of guidelines.

The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension

Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy

Nebivolol: a third-generation beta-blocker for hypertension.

Polymorphism of human cytochrome P450 enzymes and its clinical impact.

Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.

P304

807-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.2334

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiao-yang Zhou

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098786

http://www.w3.org/2001/XMLSchema#string

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

about

P2860

P2860

Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698